Navigation Links
Compressed DNA aids gene patients

Scientists have invented a method of compressing DNA which could make gene therapy powerful. The advance which is now being tried out on cystic fibrosis patients, may allow the modified genes to slip right into the cell nucleus.A single strand of DNA contains a complete blueprint for building an entire human.//

This means that the DNA molecule is long and unwieldy. Doctors are looking for ways to smuggle or slip their modified DNA strands into the cells they want to change.

Other methods involve using viruses - which "infect" the cell and pass on the new genes that way, or encasing the DNA in fatty globules called liposomes, which are pulled into the cell by a natural process.

However, infecting patients with viruses carries its own risks, and liposome production is less efficient. The new technique involves taking the long strands of DNA and "scrunching" them up into a more compact package.

This tiny ball, 25 nanometres across - 25 millionths of a millimetre - is much smaller than a liposome, and should be able to pass into the nucleus of a cell through pores in its surface, say the scientists. In cells in a test tube, the tiny DNA packets appeared to be as much as 6,000 times more effective at getting their genes working in the nuclei of cells than DNA-carrying liposomes.

Now basic safety trials have begun involving human patients, suffering from cystic fibrosis also. This disorder, which involves faulty production of the mucus which lines the lungs, is caused by a single faulty gene.


'"/>




Page: 1

Related medicine news :

1. HIV infected patients can travel safely abroad
2. New vaccine helps allergy and asthma patients
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. New vaccine helps allergy and asthma patients
5. Are cancer patients being taken for a ride?
6. Alternative medicine more popular among HIV positive patients
7. ATG useful in transplant patients as substitute for steroids
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Distraction therapy found very effective in postoperative patients
10. Cancer patients turning to Internet for information
11. Helping stroke patients to recover balance
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Meeting through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on ... in 26 people will be diagnosed with epilepsy within their lifetime. With such ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... interoperability, today announced that the company will provide alerting technology to Central ... been recently awarded $1.7 million in federal funds as the sole sub-recipient ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one ... Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the ... techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Officer for the Florida Hospital West Florida Region. McGuinness brings experience in executive ... and engaging staff, physicians and leaders. , In her new role, that officially ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016  BD (Becton, Dickinson ... global medical technology company, will demonstrate an enhanced technology ... management technologies, including the company,s leading Pyxis™ and Alaris™ ... Pharmacists (ASHP) 2016 Midyear Meeting being held in ... While national data show that approximately 68 ...
(Date:12/5/2016)... Research and Markets has announced the addition of the "Global ... and Demand Forecast to 2022" report to their offering. ... , , ... market is expected to grow at a CAGR of 4.5% during ... witnessing high growth, due to growing female geriatric population and increasing ...
(Date:12/5/2016)... England , December 5, 2016 ... Transitions to Deputy Chairman   ... on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative ... has been appointed as non-executive Chairman, effective January 1 st ... of Mission Therapeutics as a non-executive Director in July 2015. ...
Breaking Medicine Technology: